1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow pexacerfont: new trials by email Literature Review of pexacerfont trials Research Report on pexacerfont
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder pexacerfont, escitalopram, placebo - Generalized Anxiety Disorder | Phase 2 / Phase 3 | Completed | Bristol-Myers Squibb | 260 | 2007-07-01 | 2015-10-12 |
Generalized Anxiety Disorder (1)
United States (1)